1. Home
  2. BLMN vs IRWD Comparison

BLMN vs IRWD Comparison

Compare BLMN & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bloomin' Brands Inc.

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$8.85

Market Cap

714.0M

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.72

Market Cap

658.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLMN
IRWD
Founded
1988
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
714.0M
658.5M
IPO Year
2012
2009

Fundamental Metrics

Financial Performance
Metric
BLMN
IRWD
Price
$8.85
$3.72
Analyst Decision
Hold
Buy
Analyst Count
8
3
Target Price
$7.88
$7.67
AVG Volume (30 Days)
1.7M
2.1M
Earning Date
05-06-2026
05-11-2026
Dividend Yield
4.99%
N/A
EPS Growth
106.71
1400.00
EPS
0.65
0.24
Revenue
$4,213,346,000.00
$298,276,000.00
Revenue This Year
$2.07
$57.95
Revenue Next Year
$1.81
$4.39
P/E Ratio
$13.55
$14.83
Revenue Growth
N/A
8.88
52 Week Low
$5.19
$0.72
52 Week High
$9.28
$5.78

Technical Indicators

Market Signals
Indicator
BLMN
IRWD
Relative Strength Index (RSI) 58.99 38.43
Support Level $7.16 $3.08
Resistance Level $9.28 $3.95
Average True Range (ATR) 0.39 0.20
MACD 0.01 -0.07
Stochastic Oscillator 85.71 0.91

Price Performance

Historical Comparison
BLMN
IRWD

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a biotechnology company developing and commercializing life-changing therapies for people living with gastrointestinal, or GI, and rare diseases. It is focused on the development and commercialization of inventive product opportunities in areas of unmet need, leveraging its demonstrated expertise and capabilities in GI and rare diseases. LINZESS is its commercial product. LINZESS is also available for the treatment of adults with IBS-C or CIC in Mexico, adults with IBS-C or chronic constipation in Japan, and adults with IBS-C in China. Linaclotide is available under the trademarked name CONSTELLA for the treatment of adults with IBS-C or CIC and pediatric patients ages 6-17 years old with FC in Canada, and to adults with IBS-C in certain European countries.

Share on Social Networks: